ArticleJournal of oncology2020

GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial.

Ruinuo Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.